By UK Chemo Board on 11th April 2022

Date for Diary – The UK Chemotherapy Board Annual Conference 2022

We are delighted to announce that this year’s UK Chemotherapy Board Annual Conference will take place face-to-face on Tuesday 29th November at the Pullman London St Pancras Hotel. We will…

Read article
By BOPA on 23rd March 2022

My CML app

Two BOPA members, Andrea Preston and Nick Duncan, have just launched a new, free patient support app for CML patients.  They are keen to raise awareness, so please spread the…

Read article
By BOPA Committee on 23rd March 2022

Call for Abstracts for BOPA 2022 symposium –  Now Open!

Delegates are invited to present results of their clinical and technical work as a poster with some selected for oral presentation. The author/s should submit via the BOPA website by noon on…

Read article
By UK Chemo Board on 4th February 2022

PUBLISHED by UKCB: Standards for the safer use of ePMA systems for use in SACT Services

Please click here to see version 3.0 of the Standards for the safer use of ePMA systems for use in SACT Services. We would like to thank everyone involved in all…

Read article
By UK Chemo Board on 4th February 2022

PUBLISHED by UKCB: Position Statement on Hepatitis B Virus Screening and Reactivation Prophylaxis for Patients Planned to Receive Immunosuppressive SACT

Dear All,   Please click here to see the final version of the Position Statement on Hepatitis B Virus Screening and Reactivation Prophylaxis for Patients Planned to Receive Immunosuppressive SACT…

Read article
By UK Chemotherapy Board on 4th February 2022

PUBLISHED by UKCB: National SACT Protocols: Options Appraisal

For information – please click here to see the final version of the National SACT Protocols: Options Appraisal. https://www.ukchemotherapyboard.org/publications The UK Chemotherapy Board will discuss the next steps at our next meeting. Kind regards,…

Read article
By BOPA on 19th January 2022

2022 UK Interdisciplinary Breast Cancer Symposium

Don’t forget to register for the 2022 UK Interdisciplinary Breast Cancer Symposium to be held on-line on Monday 24 January and Tuesday 25 January. Registration for this meeting is free.…

Read article
By BOPA Committee on 21st December 2021

UPDATED: Clinician FAQS and guidance on COVID-19 vaccine

The Clinician FAQS and guidance on COVID-19 vaccine for patient receiving SACT. Version 6.0. Updated 21st December 2021 is now available on the UKCB website here: https://www.ukchemotherapyboard.org/publications.  This updated guidance…

Read article
By BOPA Committee on 21st December 2021

Equality, Diversity and Inclusion

The British Oncology Pharmacy Association is committed to champion equality, diversity and inclusion (EDI) in order to create a positive environment for all. Therefore, we would like to invite interested…

Read article
By BOPA Committee on 17th November 2021

ISOPP: Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) Program

The International Society of Oncology Pharmacy Practitioners (ISOPP) offers educational opportunities specific to the needs of oncology pharmacy practitioners worldwide.   Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) Program consists of…

Read article
By BOPA Committee on 17th November 2021

ISOPP 2022 Virtual Symposium

ISOPP 2022 Virtual Symposium – taking place March 4-5, 2022. Save the dates and watch for program announcements!   o    Engage in hot topics led by facilitators on a wide…

Read article
By Alia Nizam on 15th October 2021

Breast regimen-specific consent forms

Dear All,   I am pleased to inform you that the breast regimen-specific consent forms have been updated with the following: Subcutaneous administration option for regimens containing Trastuzumab  and Pertuzumab.…

Read article